The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population

MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL and the University of Oxford today announced that results from the SYMPLIFY study have been published in The Lancet Oncology.

ADVERTISEMENT — Advertise With Biotech Networks